These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 6130076)

  • 1. Assessment of the abuse liability of buspirone in recreational sedative users.
    Cole JO; Orzack MH; Beake B; Bird M; Bar-Tal Y
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):69-75. PubMed ID: 6130076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the abuse liability of buspirone in alcohol-dependent patients.
    Griffith JD; Jasinski DR; Casten GP; McKinney GR
    Am J Med; 1986 Mar; 80(3B):30-5. PubMed ID: 3963032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users.
    Abanades S; Farré M; Barral D; Torrens M; Closas N; Langohr K; Pastor A; de la Torre R
    J Clin Psychopharmacol; 2007 Dec; 27(6):625-38. PubMed ID: 18004131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chronically administered buspirone and diazepam on driving-related skills performance.
    Moskowitz H; Smiley A
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):45-55. PubMed ID: 6130073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
    Johnson MW; Suess PE; Griffiths RR
    Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of the abuse liability of alprazolam, lorazepam, diazepam, methaqualone, and placebo.
    Orzack MH; Friedman L; Dessain E; Bird M; Beake B; McEachern J; Cole JO
    Int J Addict; 1988 May; 23(5):449-67. PubMed ID: 3061941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychological effects of buspirone.
    Lader M
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):62-8. PubMed ID: 6130075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative drug effects and abuse liability of lorazepam, buspirone, and secobarbital in nondependent subjects.
    Sellers EM; Schneiderman JF; Romach MK; Kaplan HL; Somer GR
    J Clin Psychopharmacol; 1992 Apr; 12(2):79-85. PubMed ID: 1573044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the abuse potential of pagoclone, a partial GABAA agonist.
    de Wit H; Vicini L; Haig GM; Hunt T; Feltner D
    J Clin Psychopharmacol; 2006 Jun; 26(3):268-73. PubMed ID: 16702891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tandospirone and alprazolam: comparison of behavioral effects and abuse liability in humans.
    Evans SM; Troisi JR; Griffiths RR
    J Pharmacol Exp Ther; 1994 Nov; 271(2):683-94. PubMed ID: 7965783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abuse liability assessment of atomoxetine in a drug-abusing population.
    Jasinski DR; Faries DE; Moore RJ; Schuh LM; Allen AJ
    Drug Alcohol Depend; 2008 May; 95(1-2):140-6. PubMed ID: 18328639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The side effect profile of buspirone in comparison to active controls and placebo.
    Newton RE; Casten GP; Alms DR; Benes CO; Marunycz JD
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):100-2. PubMed ID: 6130065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methaqualone.
    Ionescu-Pioggia M; Bird M; Orzack MH; Benes F; Beake B; Cole JO
    Int Clin Psychopharmacol; 1988 Apr; 3(2):97-109. PubMed ID: 3397524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of diazepam and buspirone on subjective feelings, psychological tests and the EEG.
    Bond AJ; Lader MH
    Int Pharmacopsychiatry; 1981; 16(4):212-20. PubMed ID: 6121766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do formulation differences alter abuse liability of methylphenidate? A placebo-controlled, randomized, double-blind, crossover study in recreational drug users.
    Parasrampuria DA; Schoedel KA; Schuller R; Silber SA; Ciccone PE; Gu J; Sellers EM
    J Clin Psychopharmacol; 2007 Oct; 27(5):459-67. PubMed ID: 17873677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Buspirone: a clinical review of a new, non-benzodiazepine anxiolytic".
    Uhlenhuth EH
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):109-16. PubMed ID: 6130067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abuse liability of buprenorphine--a study among experienced drug users.
    Bedi NS; Ray R; Jain R; Dhar NK
    Indian J Physiol Pharmacol; 1998 Jan; 42(1):95-100. PubMed ID: 9513799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative abuse liability of indiplon and triazolam in humans: a comparison of psychomotor, subjective, and cognitive effects.
    Carter LP; Griffiths RR; Suess PE; Casada JH; Wallace CL; Roache JD
    J Pharmacol Exp Ther; 2007 Aug; 322(2):749-59. PubMed ID: 17502431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds.
    Griffiths RR; Johnson MW
    J Clin Psychiatry; 2005; 66 Suppl 9():31-41. PubMed ID: 16336040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug preference in humans: double-blind choice comparison of pentobarbital, diazepam and placebo.
    Griffiths RR; Bigelow GE; Liebson I; Kaliszak JE
    J Pharmacol Exp Ther; 1980 Dec; 215(3):649-61. PubMed ID: 7441524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.